Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer (vol 18, 43, 2019)

被引:8
|
作者
Liu, Tong [1 ]
Zhang, Xin [2 ]
Du, Lutao [1 ]
Wang, Yunshan [1 ]
Liu, Xiaoming [3 ]
Tian, Hui [4 ]
Wang, Lili [2 ]
Li, Peilong [1 ]
Zhao, Yinghui [1 ]
Duan, Weili [1 ]
Xie, Yujiao [1 ]
Sun, Zhaowei [5 ]
Wang, Chuanxin [1 ]
机构
[1] Shandong Univ, Hosp 2, Dept Clin Lab, 247 Beiyuan St, Jinan 250033, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250012, Shandong, Peoples R China
[3] Shandong Prov Tradit Chinese Med Hosp, Dept Prevent Med, Jinan 250012, Peoples R China
[4] Shandong Univ, Qilu Hosp, Ctr Canc, Jinan 250012, Shandong, Peoples R China
[5] Qingdao Univ, Dept Surg, Coll Med, Affiliated Hosp, Qingdao 266071, Shandong, Peoples R China
关键词
D O I
10.1186/s12943-020-01211-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
页数:2
相关论文
共 40 条
  • [21] RETRACTION: Exosomal miR-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 signaling
    Bai, J.
    Zhang, X.
    Shi, D.
    Xiang, Z.
    Wang, S.
    Yang, C.
    Liu, Q.
    Huang, S.
    Fang, Y.
    Zhang, W.
    Song, J.
    Xiong, B.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [22] Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p
    Han, Wei
    Yin, Hongli
    Ma, Hao
    Wang, Yi
    Kong, Desong
    Fan, Zhimin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [23] CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p (vol 18, 86, 2019)
    Wang, Lu
    Yang, Guang
    Zhao, Danfeng
    Wang, Jiaqi
    Bai, Yang
    Peng, Qiang
    Wang, Hongzhi
    Fang, Ruizhe
    Chen, Guang
    Wang, Zhichao
    Wang, Keliang
    Li, Guangbin
    Yang, Yinhui
    Wang, Ziqi
    Guo, Pengyu
    Peng, Li
    Hou, Dayong
    Xu, Wanhai
    MOLECULAR CANCER, 2020, 19 (01)
  • [24] IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway (vol 13, pg 2379, 2021)
    Zhou, X.
    Feng, Y.
    Liu, S.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2907 - 2907
  • [25] RETRACTION: Influence of miR-376c-3p/SYF2 Axis on the Progression of Gastric Cancer (Retraction of Vol 18, art no 1533033819874808, 2019)
    Liu, Bin
    Li, Guangchun
    Zhang, Zhen
    Wu, Honglei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [26] RETRACTION: LncRNA OIP5-AS1 contributes to ox-LDL-induced inflammation and oxidative stress through regulating the miR-128-3p/CDKN2A axis in macrophages (Retraction of Vol 9, Pg 41709, 2019)
    Fisher, Laura
    RSC ADVANCES, 2021, 11 (09) : 5241 - 5241
  • [27] miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 (vol 12, pg 10275, 2019)
    Jiang, W.
    Li, T.
    Wang, J.
    ONCOTARGETS AND THERAPY, 2020, 13 : 5589 - 5589
  • [28] LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis (vol 18, 167, 2019)
    Hu, Yun-ping
    Jin, Yun-peng
    Wu, Xiang-song
    Yang, Yang
    Li, Yong-sheng
    Li, Huai-feng
    Xiang, Shan-shan
    Song, Xiao-ling
    Jiang, Lin
    Zhang, Yi-jian
    Huang, Wen
    Chen, Shi-li
    Liu, Fa-tao
    Chen, Chen
    Zhu, Qin
    Chen, Hong-zhuan
    Shao, Rong
    Liu, Ying-bin
    MOLECULAR CANCER, 2021, 20 (01)
  • [29] CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p (vol 18, 25, 2019)
    Rong, Dawei
    Lu, Chen
    Zhang, Betty
    Fu, Kai
    Zhao, Shuli
    Tang, Weiwei
    Cao, Hongyong
    MOLECULAR CANCER, 2020, 19 (01)
  • [30] RETRACTION: IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway (vol 13, pg 2379, 2021) (Retraction of Vol 13, Pg 2379, 2021)
    Zhou, X.
    Feng, Y.
    Liu, S.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 823 - 823